Navidea Biopharmaceuticals Incの売上総利益

Navidea Biopharmaceuticals Incの売上総利益 は何ですか。

Navidea Biopharmaceuticals Incの売上総利益 は97.04%です。

売上総利益 の定義は何ですか。



売上総利益は、売上と商品の売上原価との差を収益で除してパーセンテージで表したものです。

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

NYSEMKTのセクタHealth Careにおける売上総利益 の企業と比べるNavidea Biopharmaceuticals Inc

Navidea Biopharmaceuticals Incは何をしますか。

navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de

Navidea Biopharmaceuticals Incと類似の売上総利益